The transistor technology developer has disclosed $21.8m in series A funding from investors including Agilent Technologies across three tranches.

American Family’s venture capital unit has contributed to a $22.5m round that will support the digital mortgage lender's US expansion.

Weill Cornell Medicine‘s monogenic diseases therapy developer Lexeo Therapeutics has made its public debut with $85m in series A financing.

Genomic drug developer Tessera Therapeutics raised $230m in a round co-led by SoftBank Vision Fund 2 as it works on its gene writing technology.

GV helped longtime portfolio company and database platform developer Cockroach Labs take its total funding to $355m at a $2bn valuation.

Monogenic disease therapy developer Lexeo Therapeutics has publicly launched with financing from backers including Lundbeckfonden Ventures.

The Access Industries and Volkswagen-backed business transport platform developer has added $15m to a round valuing it at $1.5bn.

The Workday, Salesforce and ServiceNow-backed workflow automation software provider boosted its valuation to $1.7bn and its overall funding to over $220m.

The CreditEase and Mouro Capital-backed payment technology provider lured personal finance firm OneMain Financial to co-lead its series C round.

LifeMine’s chairman and co-founder Rick Klausner has co-led a round that included multiple corporates and pushed the overall equity to $120m.